Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2003
07/15/2003US6592869 Stable compressed freeze dried antigen and dissolution aid
07/15/2003US6592860 Composition and applicator for topical substance delivery
07/15/2003US6592850 Sildenafil citrate chewing gum formulations and methods of using the same
07/15/2003US6592849 Mixture of zinc compound and phosphate
07/15/2003US6592848 Ready to use aerosol packages
07/15/2003US6592844 Preparation of protein microspheres, films and coatings
07/15/2003US6592843 Liposome mixture containing chelator solution and alpha particle emitting radionuclides; cancer therapy
07/15/2003US6592671 Apparatus for clamping a planar substrate
07/15/2003US6592571 Drug pump with suture loops flush to outer surface
07/15/2003CA2133421C Process for the preparation of microcapsules or liposomes of controlled sizes
07/10/2003WO2003056028A1 Improved method of producing lycopene through the fermentation of selected strains of blakeslea trispora, formulations and uses of the lycopene thus obtained
07/10/2003WO2003055942A1 Heteroxylan film-forming composition for making capsules and resulting capsules
07/10/2003WO2003055917A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/10/2003WO2003055855A1 Method of obtaining novel lutein-based formulations
07/10/2003WO2003055834A2 Method for the production of $g(a) mannite directly compressible into tablets
07/10/2003WO2003055590A2 Switchable surfaces
07/10/2003WO2003055584A2 Granules obtained by drying an emulsion comprising a polymer and a monosaccharide or a monosaccharide derivative
07/10/2003WO2003055549A1 Metered dose inhaler
07/10/2003WO2003055547A1 Medicament dispenser
07/10/2003WO2003055531A2 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
07/10/2003WO2003055525A1 Acid-containing preparations
07/10/2003WO2003055512A1 Liquid composition of factor vii polypeptides
07/10/2003WO2003055504A1 Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation
07/10/2003WO2003055500A1 Pharmaceutical compositions for the treatment or prevention of osteoporosis
07/10/2003WO2003055498A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
07/10/2003WO2003055495A1 ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17β-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION
07/10/2003WO2003055493A1 Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation
07/10/2003WO2003055486A1 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity
07/10/2003WO2003055475A1 Controlled release pharmaceutical formulation containing venlafaxine
07/10/2003WO2003055474A1 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
07/10/2003WO2003055472A1 Gel comprising at least a retinoid and benzoyl peroxide
07/10/2003WO2003055471A1 Adhesive transdermal formulations of diclofenac sodium
07/10/2003WO2003055470A1 Novel microsphere and method for production thereof
07/10/2003WO2003055469A1 Improved polymer-lipid delivery vehicles
07/10/2003WO2003055468A1 Oral capsule formulation with increased physical stability
07/10/2003WO2003055467A1 Simvastatin dosage forms
07/10/2003WO2003055466A1 Microemulsion preconcentrate
07/10/2003WO2003055465A1 Preparation for the topical anaesthesia of the skin
07/10/2003WO2003055464A1 Micronized pharmaceutical or nutraceutical powder with immediate release
07/10/2003WO2003055456A1 Stable surfactant compositions for suspending components
07/10/2003WO2003055454A1 New composition
07/10/2003WO2003055445A2 Compositions and methods for enhancing corticosteriod delivery
07/10/2003WO2003055442A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
07/10/2003WO2003055424A1 METHOD OF SYSTEMICALLY DELIVERING SSRIs
07/10/2003WO2003055410A2 Composition and method for treatment of otitis externa
07/10/2003WO2003055323A1 Seal oil based lipid emulsions and uses thereof
07/10/2003WO2003039437A3 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel
07/10/2003WO2003037298A3 Bowel cleansing agent
07/10/2003WO2003035107A8 Enzyme inhibitors for inactivating allergens
07/10/2003WO2003028703A3 Immediate release tablet
07/10/2003WO2003022250A3 Unilamellar vesicles stabilized with short chain hydrophilic polymers
07/10/2003WO2003020203A3 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments
07/10/2003WO2003017932A3 Compositions and methods for targeting cerebral circulation and treatment of headache
07/10/2003WO2003015698A3 Application of lipid vehicles and use for drug delivery
07/10/2003WO2003011227A3 Taste masking composition
07/10/2003WO2003002175A8 Enhanced systemic absorption of intradermally delivered substances
07/10/2003WO2002096368A3 Encapsulation of nanosuspensions in liposomes and microspheres
07/10/2003WO2002026262A3 Compositions for reducing side effects in chemotherapeutic treatments
07/10/2003WO2002009675A9 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release
07/10/2003US20030130647 Infusion device and driving mechanism for same
07/10/2003US20030130575 Method and apparatus for tissue treatment with laser and electromagnetic radiation
07/10/2003US20030130558 Intravaginal devices containing progesterone for estrus synchronization and related proceses
07/10/2003US20030130472 Bioerodible poly (orthoesters)from dioxolane-based diketene acetals
07/10/2003US20030130427 Two-phase, water-absorbent bioadhesive composition
07/10/2003US20030130359 Anesthetic comprising sevoflurane, enflurane, isoflurane, methoxyflurane, and/or desflurane stabilized with water, butylated hydroxytoluene, methylparaben, propylparaben, propofol, and thymol
07/10/2003US20030130351 Aersol forms of L-3,5,3',5'-tetraiodothyronine; dietetics
07/10/2003US20030130338 Method of treatment
07/10/2003US20030130314 Administering 4-amido-piperidineo derivatives to patients already under the background influence of an opioid agonist
07/10/2003US20030130310 Quinolinone derivative pharmaceutical compositon and production method therefor
07/10/2003US20030130300 Respiratory system disorders; synergistic mixtures
07/10/2003US20030130299 Administering dosage of immunology response moderator
07/10/2003US20030130297 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
07/10/2003US20030130268 Mixture containing water soluble polymer and surfactant; antiinflammatory agents, antiulcer agents, Crohn's disease
07/10/2003US20030130267 Midazolane maleate in water, alcohol solution
07/10/2003US20030130263 Mixture of two antihistamines; sustained release
07/10/2003US20030130248 Topical anti-inflammatory compositions
07/10/2003US20030130247 Compositions and methods for enhancing corticosteroid delivery
07/10/2003US20030130245 Stabilized aqueous suspensions for parenteral use
07/10/2003US20030130244 Mixture of estrogen, androgen and anticholinergic agent
07/10/2003US20030130243 Hormone replacement therapy
07/10/2003US20030130231 2:1 Complex of beta- or gamma-cyclodextrin and alpha-tocopherol
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030130211 Injectable compositions for the controlled delivery of pharmacologically active compound
07/10/2003US20030130207 Use of borate-polyol complexes in ophthalmic compositions
07/10/2003US20030130203 Sleep disorders
07/10/2003US20030130192 Administration of leptin
07/10/2003US20030130183 Adjust permeability of skin membrane; topical applying urogenital system
07/10/2003US20030130176 Spary drying dispersion; antiinflammatory agents; antihistamines; lung diseases
07/10/2003US20030129678 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
07/10/2003US20030129295 Comprises protective lipid coating (hydrogenated oils) for choline chloride or lysine hydrochloride; ruminant feeds
07/10/2003US20030129268 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dematology, in cosmetics and as food additive
07/10/2003US20030129252 Triggered release from proteinoid microspheres
07/10/2003US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier
07/10/2003US20030129250 Particulate compositions for improving solubility of poorly soluble agents
07/10/2003US20030129249 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
07/10/2003US20030129248 Microcapsule, in particular, for immobilizing organic or inorganic solids, liquids and/or gases
07/10/2003US20030129246 Process for preparing solid dosage forms of very low-dose drugs
07/10/2003US20030129245 Mixing micronised formoterol its salt or solvate with a pre-micronised carrier/diluent at low energy, agglomerating and spheronisation or adding a coarse carrier/diluent; treating respiratory system disorders
07/10/2003US20030129244 Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations
07/10/2003US20030129243 Transfection of nucleic acid into a cell and/or organ